Skip to content

Pharma Systems Eesti Osaühing

Registry code (registrikood) 10329988Private limited company (Osaühing)VAT EE100456651Activity (EMTAK 32509): Muude meditsiiniinstrumentide ning materjalide tootmineActive

Hiiumaa vald, Hiiu County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€929k
▲ 8.4% vs 2024
Profit before tax (2025)
€44k
Employees, FTE (2025)
23
State taxes paid, last 4 quarters
€239k

Revenue, profit and employees, 2019–2025

€906k2019€1.0M2020€1.0M2021€1.5M2022€935k2023€857k2024€929k2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€905,670€43,921€36,825€522,47530
2020€1,026,880€39,052€33,770€556,24536
2021€1,005,182€56,030€53,190€609,43534
2022€1,546,095€32,016€71,975€841,27732
2023€934,702€44,287€44,274€885,55125
2024€857,294€40,323€40,314€925,86523
2025€929,441€44,220€44,176€970,04123

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€56,861€919,006€396,531—€522,475
2020€61,323€975,741€419,496—€556,245
2021€77,625€1,019,425€409,990—€609,435
2022€41,964€973,635€132,358—€841,277
2023€64,734€1,002,102€116,551—€885,551
2024€39,914€1,041,988€116,123—€925,865
2025€77,857€1,097,550€127,509—€970,041

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€64,150€68,593€242,83033
2022 Q2€62,111€66,201€262,12932
2022 Q3€67,827€72,121€207,98532
2022 Q4€68,656€72,779€277,97832
2023 Q1€66,529€70,440€276,26932
2023 Q2€70,167€73,860€281,71429
2023 Q3€68,466€72,388€203,65326
2023 Q4€62,764€66,474€237,53426
2024 Q1€60,664€63,939€235,69426
2024 Q2€66,125€69,802€254,20023
2024 Q3€63,936€67,405€192,02423
2024 Q4€56,884€60,364€217,66422
2025 Q1€54,991€58,051€217,41424
2025 Q2€57,805€61,050€231,51524
2025 Q3€60,918€64,449€198,83224
2025 Q4€62,701€66,268€242,00124
2026 Q1€58,519€62,007€240,22924
2026 Q2€57,599€61,066€241,42924
2026 Q3€59,789€63,654€195,13823

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 July 2025–30 June 2026), Pharma Systems Eesti Osaühing reported revenue of €929,441.

The company closed the 2025 financial year with a net profit of €44,176.

Revenue increased by 8.4% from €857,294 in 2024 to €929,441 in 2025.

Revenue grew at a compound annual rate of 0.4% between 2019 and 2025.

Equity accounted for 88.4% of total assets of €1,097,550 at the end of the 2025 reporting period.

With 23 full-time-equivalent employees in 2025, revenue per employee was €40,410.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, Pharma Systems Eesti Osaühing reported €918,797 in turnover.

EMTA recorded 23 employees for the quarter ending Q3 2026, compared with 23 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.